Status:
COMPLETED
Effective Communication for Preventing and Responding to Oncology Adverse Events
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
Cancer patients often experience problems in their care, many of which are caused by communication breakdowns. Some communication breakdowns lead to adverse events and even harmful errors. Deficiencie...
Eligibility Criteria
Inclusion
- Cancer survivors
- 21 to 80 years of age
- Able to communicate in English
- have adequate hearing
- no cognitive impairments
Exclusion
- Any non-melanoma skin cancer, Breast cancer in situ, Cervical intraepithelial neoplasia (CIN): types I, II, III, Stage I colon cancer, Stage IV cancer, Recurrent cancer or second primary
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2013
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01871948
Start Date
October 1 2008
End Date
August 1 2013
Last Update
December 16 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Georgia
Atlanta, Georgia, United States, 30305
2
Group Health
Seattle, Washington, United States, 98124